Patient-tailored physical activity plan for older women with gynecologic cancer during chemotherapy

Who could benefit from this research

What this research studies

This project develops an mHealth-based physical activity program for older women with gynecologic cancer who are receiving chemotherapy. Using a multi-phase optimization strategy, participants will be randomly assigned to different combinations of program components to see which parts best boost physical activity and maintain it after the intervention. The study emphasizes accessibility, accommodating symptom-related fluctuations, and leveraging mobile technology to support activity at home. Results will inform which elements are most helpful to reduce frailty and improve quality of life during treatment.

Why it matters

Where this research is happening

• Northwestern University
  Chicago, United States Active

Researchers

• Principal investigator: Barber, Emma — Northwestern University
• Study coordinator: Barber, Emma

Related research

Other NIH-funded projects on the same topics.

• Tailored physical activity program for older women with gynecologic cancers undergoing chemotherapy

  This study is testing a helpful mobile program called Fit4Treatment that aims to encourage older women with gynecologic cancers who are going through chemotherapy to be more active and improve their quality of life, all while providing personalized exercise plans that fit their needs.

  NIH research Northwestern University at Chicago · Chicago, United States · NIH-11077746

• Photodynamic lipids to boost chemotherapy for metastatic ovarian cancer

  A patient-friendly approach tests a light-activated method to make ovarian cancer metastases more sensitive to chemotherapy.

  NIH research Utah State Higher Education System--University of Utah · Salt Lake City, United States · NIH-11601571

• Dual targeting of heart cell receptors to prevent chemotherapy heart damage

  Atrial patients receiving the chemotherapy drug doxorubicin may be protected from heart damage by targeting two heart cell receptors at once.

  NIH research University of Arizona · Tucson, United States · NIH-11536674

• A 3D ultrasound scanner to see early chemotherapy response in breast cancer

  A new 3D ultrasound imaging method will be tested to see if it can quickly show whether breast cancer is responding to chemotherapy.

  NIH research University of Illinois at Urbana-Champaign · Champaign, United States · NIH-11535270

• Non-invasive, microscopic biomarkers to detect CIPN in chemotherapy patients

  This grant aims to develop a non-invasive imaging method to measure nerve changes in patients undergoing chemotherapy to better understand and monitor chemotherapy-induced peripheral neuropathy (CIPN).

  NIH research University of Arizona · Tucson, United States · NIH-11473607

• Alternative NF-kB activation after chemotherapy in ovarian cancer

  This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

  NIH research San Diego State University · San Diego, United States · NIH-11473227

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.